Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CCR7 (clone 1G2E1GG1G2E). We employs the pUC (SV40-YFP-c-Jun-KpnI) vector components and the SynExpress system of the miRNA Prime Editing/Negative feedback for a robust and sustained response against cancers.
Host
mouse
Target
CCR7
Clone
1G2E1GG1G2E
Species Reactivity
human
Cell Source
Modified CD8+ T cells
Sensor Gene
YFP
Promoter
SV40
Effector Gene
c-Jun
Insertion Sites
KpnI
Gene Modification
Prime Editing
Modification Domain
miRNA
Carrier Type
pUC
Transformation Accuracy
0.98
Cell Culture
Suspension Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.